|Articles|September 14, 2022

ObvioHealth Introduces ObvioGo

DCT platform to deliver stronger evidence of therapeutic efficacy and safety.

ObvioHealth announces the launch of ObvioGo, a decentralized clinical trial platform and mobile application.

ObvioGo's tech stack has been designed to capture and integrate multi-source data. The system incorporates digital instruments, real-world data, artificial intelligence, as well as integration with clinical systems via APIs and industry standard interfaces.

Read more about the new platform here.

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!

Related Content